Professional Seasonal Analysis for Trading

Verrica Pharmaceuticals Inc. - Common Stock (VRCA)

Seasonality Analysis

Stocks 8 Years Analyzed

Verrica Pharmaceuticals Inc. - Common Stock Annual Seasonality Statistics

5.79%
Avg Annual Return
40.0%
Avg Monthly Win Rate
6/12
Positive Months
8
Years Analyzed

Verrica Pharmaceuticals Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January 6.23%
25%
Weak
February 0.91%
50%
Weak
March -7.39%
25%
Very Weak
April 2.56%
50%
Weak
May WORST -12.27%
43%
Weak
June 8.81%
63%
Strong
July -5.27%
13%
Very Weak
August -1.55%
50%
Weak
September -4.98%
25%
Very Weak
October -8.48%
25%
Very Weak
November BEST 20.81%
63%
Strong
December 6.41%
50%
Weak

Verrica Pharmaceuticals Inc. - Common Stock 2026 vs Historical Pattern

Current Position
34.08
Historical Avg Position
52.26
Deviation
-18.18
Performance
Significantly Below Average

Verrica Pharmaceuticals Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for VRCA with overlay patterns, custom date ranges, and more.

Create Free Account

Verrica Pharmaceuticals Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Verrica Pharmaceuticals Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for VRCA across multiple timeframes.

Create Free Account

About Verrica Pharmaceuticals Inc. - Common Stock (VRCA) Seasonality

Verrica Pharmaceuticals Inc. - Common Stock (VRCA) has been analyzed using 8 years of historical data to identify seasonal patterns. Classified under Stocks, Verrica Pharmaceuticals Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Verrica Pharmaceuticals Inc. - Common Stock is historically November, with an average return of 20.81% and a win rate of 63%. Conversely, May tends to be the weakest month, averaging -12.27% return.

Looking at the full calendar year, Verrica Pharmaceuticals Inc. - Common Stock has an average annual return of 5.79% with an overall monthly win rate of 40.0%. Out of 12 months, 6 typically show positive average returns.

The seasonal pattern for Verrica Pharmaceuticals Inc. - Common Stock has a consistency score of 49.8 (Poor), based on 9 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Verrica Pharmaceuticals Inc. - Common Stock Seasonality FAQ

What is the best month to buy Verrica Pharmaceuticals Inc. - Common Stock (VRCA)?

Historically, November has been the best month for Verrica Pharmaceuticals Inc. - Common Stock, with an average return of 20.81% and a win rate of 63%. However, past performance does not guarantee future results.

What is the worst month for Verrica Pharmaceuticals Inc. - Common Stock (VRCA)?

Based on historical data, May has been the weakest month for Verrica Pharmaceuticals Inc. - Common Stock, with an average return of -12.27%. This is a historical observation and does not guarantee future results.

How reliable is VRCA seasonality data?

The seasonality analysis for Verrica Pharmaceuticals Inc. - Common Stock is based on 8 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Verrica Pharmaceuticals Inc. - Common Stock seasonality in my trading?

Use Verrica Pharmaceuticals Inc. - Common Stock (VRCA) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.